NCT04013347

Brief Summary

Neoadjuvant radio-chemotherapy (NRCT) represents a milestone in the treatment of selected rectal tumours. Ideal time interval between the end of NRCT and surgery is still debated; a 6-8 weeks time interval is considered optimal, but shorter or longer intervals have been associated with better oncological outcomes. Moreover, there is a lack of data about clinical postoperative outcomes and different time intervals after the end of NRCT. Here, effect that different time intervals have on postoperative complications with particular regard to the anastomotic dehiscence have been evaluated. Methods One hundred-sixty-seven patients underwent surgery after long-course NRCT. Three different time intervals were considered: (0-42; 43-56; \>57 days).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
167

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2005

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2005

Completed
10.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2017

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

June 28, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 9, 2019

Completed
Last Updated

July 9, 2019

Status Verified

July 1, 2019

Enrollment Period

10.2 years

First QC Date

June 28, 2019

Last Update Submit

July 6, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • number of patient with low tumor regression grade

    rate of low tumor regression grade (1-2)

    1 week after surgery

  • number of patient with surgical complications

    rate of surgical complications

    1 month after surgery

Secondary Outcomes (1)

  • number of patient with anastomotic dehiscence

    1 month after surgery

Study Arms (3)

Early Surgery

Surgery after ≤ 42 days from the end of neoadjuvant radio-chemotherapy

Procedure: Rectal Resection

Late Surgery

Surgery after 43-56 days from the end of neoadjuvant radio-chemotherapy

Procedure: Rectal Resection

Very Late Surgery

Surgery after 57 or more days from the end of neoadjuvant radio-chemotherapy

Procedure: Rectal Resection

Interventions

Low Anterior Resection and Abdominoperineal Resection

Early SurgeryLate SurgeryVery Late Surgery

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

One hundred and sixty-seven patients with rectal adenocarcinoma who underwent to resection after combined NRCT at University Campus Bio-Medico di Roma from January 2005 to March 2015 were retrospectively analysed.

You may qualify if:

  • \- patients with rectal adenocarcinoma who underwent to resection after combined NRCT at University Campus Bio-Medico di Roma from January 2005 to March 2015.
  • To evaluate the anastomotic dehiscence were excluded patients undergone to Abdomino-perineal resection (APR) and 4 patients for whom data were not available.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Caputo D, Angeletti S, Fiore M, Ciccozzi M, Coppola A, Cartillone M, La Vaccara V, Spagnolo G, Trodella L, Coppola R. Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single-center observational retrospective cohort study. Updates Surg. 2020 Jun;72(2):469-475. doi: 10.1007/s13304-020-00770-1. Epub 2020 Apr 18.

MeSH Terms

Conditions

Rectal Neoplasms

Interventions

Proctectomy

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, ColorectalDigestive System Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 28, 2019

First Posted

July 9, 2019

Study Start

January 1, 2005

Primary Completion

March 1, 2015

Study Completion

March 21, 2017

Last Updated

July 9, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share